NCT06365892View on ClinicalTrials.gov

Open-label Placebo (COLP) for Pain in Adolescent Idiopathic Scoliosis (AIS) Surgery+Surgical Treatment of Idiopathic Scoliosis

NARecruitingINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

January 1, 2026

Study Completion Date

January 1, 2026

Conditions
Adolescent Idiopathic Scoliosis (AIS)
Interventions
OTHER

open-label placebo

Placebo will be supplied as a 330mg tablet (manufactured by Consolidated Midland Corporation). Patients will take placebo with each oral opioid intake and 3 additional times per day beginning on POD 1.

OTHER

Treatment as usual

Each oral opioid dose is a 5mg Oxycodone tablet. Investigator shall never prescribe ibuprofen. Investigator shall always prescribe Tylenol 625mg every 8hrs (PRN).

Trial Locations (1)

94158

RECRUITING

University of California, San Francisco, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER